Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Mar. 25, 2016	Mar. 27, 2015
Cash flows from operating activities:
Net (loss) earnings	$ (7,495,000)	$ 10,909,000
Adjustments to reconcile net (loss) earnings to net cash (used) provided by operating activities:
Depreciation and amortization	6,636,000	$ 7,639,000
Restructuring expenses	276,000
Provision for deferred income taxes	(9,180,000)	$ (307,000)
Other non-cash changes, net	1,049,000	602,000
Net change in operating assets and liabilities	3,379,000	(3,343,000)
Net cash (used) provided by operating activities	(5,335,000)	$ 15,500,000
Cash flows from investing activities:
Proceeds from sale of business (see Note L)	3,500,000
Proceeds from life insurance policy	2,002,000
Acquisitions of fixed assets	(3,554,000)	$ (5,898,000)
Proceeds from sale of fixed assets	93,000	210,000
Other, net	(270,000)	1,553,000
Net cash provided (used) by investing activities	1,771,000	(4,135,000)
Cash flows from financing activities:
Payments of notes payable	0	(30,000)
Borrowings under revolving loan agreement	60,187,000	61,135,000
Repayments under revolving loan agreement	(62,191,000)	(67,100,000)
Proceeds from exercise of stock options	12,000	15,000
Dividends paid to shareholders	(2,041,000)	(3,047,000)
Dividends paid to noncontrolling interest	(192,000)	(219,000)
Excess tax benefits (shortfall) from stock compensation	(267,000)	(36,000)
Payments of withholding taxes on stock compensation	(190,000)	(313,000)
Net cash used by financing activities	(4,682,000)	(9,595,000)
Effect of exchange rate changes on cash	(1,290,000)	(2,920,000)
Net change in cash	(9,536,000)	(1,150,000)
Cash:
Beginning of period	22,936,000	24,757,000
End of period	$ 13,400,000	$ 23,607,000